marimastat has been researched along with scutellarin in 2 studies
| Studies (marimastat) | Trials (marimastat) | Recent Studies (post-2010) (marimastat) | Studies (scutellarin) | Trials (scutellarin) | Recent Studies (post-2010) (scutellarin) |
|---|---|---|---|---|---|
| 215 | 28 | 53 | 441 | 7 | 309 |
| Protein | Taxonomy | marimastat (IC50) | scutellarin (IC50) |
|---|---|---|---|
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, G; Jian, M; Li, X; Liu, Z; Song, F; Sun, X; Wang, Z; Zhang, H | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 review(s) available for marimastat and scutellarin
| Article | Year |
|---|---|
Discovery of Phenolic Matrix Metalloproteinase Inhibitors by Peptide Microarray for Osteosarcoma Treatment.
Topics: Animals; Antineoplastic Agents; Biological Products; Bone Neoplasms; Matrix Metalloproteinase 13; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Molecular Docking Simulation; Osteosarcoma; Peptides | 2022 |
1 other study(ies) available for marimastat and scutellarin
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |